Neonatal intrahippocampal glycoprotein 120 injection: The role of dopaminergic alterations in prepulse inhibition in adult rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 3, 2006, Pages 1352-1358

  Fitting, Sylvia ^a   Booze, Rosemarie M ^a   Mactutus, Charles F ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GLYCOPROTEIN GP 120; SODIUM CHLORIDE;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; MALE; NERVE CELL; NEWBORN; NONHUMAN; PERINATAL PERIOD; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ANIMALS; ANIMALS, NEWBORN; APOMORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HIV ENVELOPE PROTEIN GP120; HIV-1; N-METHYLASPARTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; STARTLE REACTION;

EID: 33747618025     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.105742     Document Type: Article

References (38)

1. Aksenov MY, Aksenova MV, Nath A, Ray PD, Mactutus CF, and Booze RM (2006) Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27:217-228.
2. Aksenova MV, Silvers JM, Aksenov MY, Nath A, Ray PD, Mactutus CF, and Booze RM (2006) HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: changes in dopamine transporter binding and immunoreactivity. Neurosci Lett 395:235-239.
3. Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, and Booze RM (2000) Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 879:42-49.
4. Barks JDE, Liu X-H, Sun R, and Silverstein FS (1997) Gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience 76:397-409.
5. Berger JR and Arendt G (2000) HIV dementia: the role of the basal ganglia and dopaminergic systems J Psychopharmacol 14:214-221.
6. Berger JR, Kumar M, Kumar A, Fernandez JB, and Levin B (1994) Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 8:67-71.
7. Braff DL, Stone C, Callaway E, Geyer MA, Glick ID, and Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343.
8. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, and Pert CB (1988) Neuronal cell killing by envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (Lond) 335:639-642.
9. Bussiere JL, Hardy LM, Peterson M, Foss JA, Garman RH, Hoberman AM, and Christian MS (1999) Lack of developmental neurotoxicity of MN rgp 120/HIV-1 administered subcutaneously to neonatal rats. Toxicol Sci 48:90-99.
10. Corasaniti MT, Piccirilli S, Paoletti A, Nistico R, Stringaro A, Malorni W, Finazzi-Agro A, and Bagetta G (2001) Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor. Neurosci Lett 312:67-70.
11. Czub S, Czub M, Koutsilieri E, Sopper S, Villinger F, Muller JG, Stahl-Hennig C, Riederer P, Ter Meulen V, and Gosztonyi G (2004) Modulation of simian immunodeficiency virus neuropathology by dopaminergic APO drugs. Acta Neuropathol 107:216-226.
12. Davis M, Mansbach RS, Swerdlow NR, Campeau S, Braff DL, and Geyer MA (1990) Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats. Psychopharmacology 102:1-4.
13. Fein G, Biggins CA, and MacKay S (1995) Delayed latency of the event-related brain potential P3A Component in HIV disease: progressive effects with increasing cognitive impairment. Arch Neurol 52:1109-1118.
14. Fitting S, Booze RM, Hasselrot U, and Mactutus CF (2006a) Intrahippocampal injections of Tat: effects on prepulse inhibition of the auditory startle response in adult male rats. Pharmacol Biochem Behav, in press.
15. Fitting S, Booze RM, and Mactutus CF (2006b) Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition of the auditory startle response. Int J Dev Neurosci 24:275-283.
16. Geyer MA and Swerdlow NR (2004) Measurement of the startle response, prepulse inhibition, and habituation, in Current Protocols in Neuroscience (Crawley JN, Gerfen CR, Rogawski MA, Sibley DR, Skolnick P, and Wray S eds) Wiley, New York.
17. Haughey NJ and Mattson MP (2002) Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J Acquir Immune Defic Syndr 31 (Suppl 2):S55-S61.
18. Hill JM, Mervis RF, Avidor R, Moody TW, and Brenneman DE (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 603:222-233.
19. Hoffman HS and Ison JR (1980) Reflex modification in the domain of startle: some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175-189.
20. Jones MV, Bell JE, and Nath A (2000) Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 14:2709-2713.
21. Lipton SA, Brenneman DE, Silverstein FS, Masliah E, and Mucke L (1995) Gp120 and neurotoxicity in vivo. Trends Pharmacol Sci 16:122.
22. Lipton SA, Sucher NJ, Kaiser PK, and Dreyer EB (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7:111-118.
23. Martinez ZA, Halim ND, Oostwegel JL, Geyer MA, and Swerdlow NR (2000) Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharmacol Biochem Behav 65:449-457.
24. Martin-Iverson MT and Else D (2000) PHNO, a selective dopamine D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats. Psychopharmacology 151:38-48.
25. Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus CF, Bell J, Hauser KF, and Mattson M (2000a) Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 14:222-227.
26. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, and Geiger JD (2000b) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47:186-194.
27. Rohr O, Sawaya BE, Lecestre D, Aunis D, and Schaeffer E (1999) Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system. Nucleic Acids Res 27:3291-3299.
28. Schapira AH (2005) Present and future APO drug gp120 treatment for Parkinson's disease. J Neurol Neurosurg Psychiatry 76:1472-1478.
29. Shoemaker JM, Saint Marie RL, Bongiovanni MJ, Neary AC, Tochen LS, and Swerdlow NR (2005) Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats. Neuroscience 135:385-394.
30. Swerdlow NR, Hanlon FM, Henning L, Kim YK, Gaudet I, and Halim ND (2001) Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization. Brain Res 898:195-203.
31. Swerdlow NR, Kuczenski R, Goins JC, Crain SK, Ma LT, Bongiovanni MJ, and Shoemaker JM (2005) Neurochemical analysis of rat strain differences in the startle gating-disruptive effects of dopamine agonists. Pharmacol Biochem Behav 80:203-211.
32. Swerdlow NR, Lipska BK, Weinberger DR, Braff DL, Jaskiw GE, and Geyer MA (1995) Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology 122:27-34.
33. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, and Geyer MA (2000) Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci 20:4325-4336.
34. Valle LD, Croul S, Morgello S, Amini S, Rappaport J, and Khalili K (2000) Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol 6:221-228.
35. Wallace DR, Dodson SL, Nath A, and Booze RM (2006) Estrogen attenuates gp120-and tat1-72-induced oxidative stress and prevents loss of dopamine transporter function. Synapse 59:51-60.
36. Wan FJ, Taaid N, and Swerdlow NR (1996) Do D1/D2 interactions regulate prepulse inhibition in rats? Neuropsychopharmacology 14:265-274.
37. Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, and Fowler JS (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127:2452-2458.
38. Winer BJ (1971) Statistical Principles in Experimental Design. McGraw-Hill, New York.